Hyperparathyroidism: all 309 studies

Page 2 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsCompletedNCT00417612Phase 3Results posted
• Cinacalcet to Treat Hypercalcemia in Renal Transplant RecipientsTerminatedNCT00415584Phase 1/2Results posted
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedNCT00379899Phase 4Results posted
• 7 Day Continuous Parathyroid Hormone IV InfusionCompletedNCT00377312Early Phase 1Results posted
• Vascular Risk After Kidney TransplantationCompletedNCT00374595Results posted
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedNCT00345839Phase 3Results posted
• Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT00285467Not applicableResults posted
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal DiseaseCompletedNCT00261950Phase 2Results posted
• A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney DiseaseCompletedNCT00257920Phase 4Results posted
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedNCT00042432Phase 2Results posted
• Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 2Results posted
• Upfront Ultrasound for Preoperative Localization in Primary HyperparathyroidismCompletedNCT07068867
• Intraoperative Identification of Parathyroid Adenomas Using PTeye™ and FLUOBEAM® LX: a Prospective Cohort StudyActive, not recruitingNCT06788223
• Near Infrared Autofluorescence Imaging in Minimally-Invasive Video-Assisted Parathyroidectomy (NIRAF MIVAP Study)CompletedNCT06779760
• Abnormally High Parathyroid Hormone Levels Worsens Outcomes in Vitamin D Depleted Critical Care PatientsActive, not recruitingNCT06711874
• STP.168 Clinical Study Protocol ParakeetActive, not recruitingNCT06499142Not applicable
• Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary HyperparathyroidismCompletedNCT06337825
• Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary HyperparathyroidismCompletedNCT06187480
• Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary HyperparathyroidismActive, not recruitingNCT06130683
• Glycemic Control, Type II Diabetes, ParathyroidectomyActive, not recruitingNCT05761743
• VATS for Resection of Mediastinal ParathyroidsCompletedNCT05696405
• A Study of SHR6508 in Secondary HyperparathyroidismStatus unknownNCT05663411Phase 2
• A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D SupplementationStatus unknownNCT05549154Not applicable
• Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCTCompletedNCT05540795
• RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT PatientsCompletedNCT05460234
• Effect of Mechanical Loading on vBMD and Geometry in Patients With Primary HyperparathyroidismCompletedNCT05426512
• Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After ParathyroidectomyCompletedNCT05382988Phase 3
• Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its TreatmentCompletedNCT05347082Not applicable
• Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal PatientsCompletedNCT05346419Not applicable
• F-18 PSMA for Localization of Parathyroid AdenomaTerminatedNCT05299632
• Effect of Vitamin D Supplement on Disease Activity in SLECompletedNCT05260255Not applicable
• A Trial of SHR6508 in Secondary HyperparathyroidismCompletedNCT05221008Phase 1
• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary HyperparathyroidismStatus unknownNCT04994080Phase 3
• Vitamin D Metabolism in Patients With Endocrine DisordersCompletedNCT04844164Phase 1
• Impact of Parathyroidectomy on Renal FunctionStatus unknownNCT04798092
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).CompletedNCT04750460Phase 3
• Surgical Outcomes in Patients With Primary Hyperparathyroidism and Unclear Preoperative Localisation StudiesCompletedNCT04740502Not applicable
• Determination of Circulating Autotaxin in Patients With GNAS or PTH AbnormalitiesCompletedNCT04671719
• Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet TreatmentCompletedNCT04637360Not applicable
• The Utility of 18F-fluorocholine PET/CT in the Imaging of Parathyroid AdenomasCompletedNCT04570033Not applicable
• Preemptive and Precise Intervention for CKD-SHPTStatus unknownNCT04523974
• IOPTH Usefulness for Predicting Successful Surgery in Secondary HyperparathyroidismCompletedNCT04484116
• Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid SurgeryCompletedNCT04344886Not applicable
• 18F-fluorocholine PET/CT for HyperparathyroidismCompletedNCT04316845Not applicable
• Preoperative Localization Strategies in Primary HyperparathyroidismCompletedNCT04305561Not applicable
• Pulmonary Function, Voice and Swallowing Symptoms After ParathyroidectomyCompletedNCT04267965
• Study on the Use of Cinacalcet in Phosphocalcic Context.Status unknownNCT04126954
• Osteoporosis in Primary HyperparathyroidismStatus unknownNCT04085419Phase 4
• Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid SurgeryStatus unknownNCT04051099Not applicable
• Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First IntentionCompletedNCT04040946Phase 3
• Cohort Trial on Perioperative Localization Techniques of Parathyroid AdenomasTerminatedNCT04013100
• Epidemiology of Pituitary Tumours: Prevalence of Associated NeoplasiaStatus unknownNCT03973450
• Swalqol in Primary HyperparathyroidismCompletedNCT03968510
• Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent PatientsCompletedNCT03937349
• Circulating miRNA in Primary HyperparathyroidismCompletedNCT03931109
• The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary HyperparathyroidismCompletedNCT03831620
• Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in AsiaCompletedNCT03822507Phase 3
• Phase 3 Study of SK-1403CompletedNCT03801980Phase 3
• Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)CompletedNCT03776058Phase 2
• Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary HyperparathyroidismCompletedNCT03774771Phase 2
• Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre StudyCompletedNCT03747029
• Feasibility of Parathyroidectomy With Exploration of 4 Parathyroid Glands in OutpatientsStatus unknownNCT03732157
• Impact of Parathyroidectomy on Vascular Calcification and Clinical Outcome in Hemodialysis PatientsCompletedNCT03724188
• Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy SubjectsCompletedNCT03660800Phase 1
• SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving HemodialysisCompletedNCT03626948Phase 3
• Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney DiseaseCompletedNCT03626246
• Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary HyperparathyroidismStatus unknownNCT03605472Not applicable
• The Longitudinal PTH-StudyCompletedNCT03464149
• The Application of Rapid PTH Test Paper in Operation of HyperparathyroidismStatus unknownNCT03434067
• FCH PET/MRI Parathyroid LocalizationCompletedNCT03324893Not applicable
• Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT03226171Phase 2
• 18F-fluorocholine PET/CT Imaging in HyperparathyroidismStatus unknownNCT03203668Not applicable
• the Study on Prognostic for Hemodialysis PatientsStatus unknownNCT03194087
• Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis PatientsCompletedNCT03182699Phase 4
• Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic NephropathyCompletedNCT03137316
• Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTCompletedNCT03123406Phase 4
• Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism.CompletedNCT03091140
• The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease PatientsStatus unknownNCT03082742Not applicable
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney DiseaseWithdrawnNCT03063190Phase 4
• Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)Status unknownNCT03053999
• Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary HyperparathyroidismStatus unknownNCT03052075
• Gene Expression in HyperparathyroidismTerminatedNCT03044600
• Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary HyperparathyroidismCompletedNCT03027349
• Intravenous Paricalcitol in Chronic Hemodialysis PatientsStatus unknownNCT03023748Phase 4
• Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary HyperparathyroidismCompletedNCT03011736Not applicable
• Effect of Parathyroidectomy on Cardiovascular HealthCompletedNCT02989428Not applicable
• Corticosteroid Rhythms in Hypoparathyroid PatientsStatus unknownNCT02986607Early Phase 1
• Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.CompletedNCT02895061Not applicable
• Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric BypassCompletedNCT02830789Not applicable
• The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia PatientsCompletedNCT02747979Phase 2/3
• Insulin Resistance in Primary HyperparathyroidismWithdrawnNCT02711059Not applicable
• Optimal HCTZ Cessation for Diagnosis of HyperparathyroidismCompletedNCT02591160Not applicable
• Phase 3 Study of KHK7580CompletedNCT02549417Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549404Phase 3
• Phase 3 Study of KHK7580CompletedNCT02549391Phase 2/3
• Bone Architectural Parameters in Postmenopausal Women Affected With Primary HyperparathyroidismCompletedNCT02539498Not applicable
• Comparison of Total Parathyroidectomy With and Without AutotransplantationStatus unknownNCT02536287Phase 3
• Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary HyperparathyroidismCompletedNCT02524041Not applicable
• Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal TransplantationCompletedNCT02523209
• Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under DialysisActive, not recruitingNCT02464072Not applicable

← Hyperparathyroidism overview